Streetbeat News

Products Services

CANF

Can-Fite BioPharma has signed an agreement with Fondazione Telethon for the co-development of Piclidenoson for Lowe Syndrome in Japan. Additional meetings with Japanese companies interested in Can-Fite's oncology and dermatology indications are also planned.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:20 am

LLY

The FDA has approved FoundationOne CDx as a companion diagnostic for Eli Lilly's Retevmo (selpercatinib) for certain patients with solid tumors. This approval could potentially increase the usage of Retevmo, thereby boosting Eli Lilly's revenues.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:13 am

TNXP

Tonix Pharmaceuticals has provided an overview of its TNX-2900 program for Prader-Willi Syndrome at the Foundation for Prader-willi Research Family Conference.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:11 am

BTCUSD

DOGEUSD

ETHUSD

Former President Donald Trump's sale of non-fungible tokens (NFTs) has been criticized by his niece, Mary Trump, who called it a scam. Instead, she suggested investing in major cryptocurrencies such as Bitcoin, Ethereum, and Dogecoin. If one had invested $100 in each of these cryptocurrencies on January 20, 2021, the total investment would now be worth approximately $357.21.

Portfolio Pulse from Mehab Qureshi

October 09, 2023 | 11:11 am

BYDDF

TSLA

Tesla, Inc. (NASDAQ:TSLA) stock is facing headwinds in premarket trading due to geopolitical tensions and concerns over the Israel-Hamas conflict potentially disrupting oil supplies. The company's stock is also affected by a decrease in China sales and concerns over price cuts and delays in the launch of the Cybertruck. In premarket trading, Tesla declined by 1.65%, trading at $256.22.

Portfolio Pulse from Shanthi Rexaline

October 09, 2023 | 11:07 am

PLX

Protalix BioTherapeutics has announced that its operations have not been adversely affected by the current security situation in Israel. The company does not anticipate any disruption to the supply of its products Elfabrio® or Elelyso®.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:07 am

PSNY

Polestar, a Swedish electric vehicle manufacturer, will showcase its full model line-up and future technologies at an event in Los Angeles on November 9. The event, dubbed 'Polestar Day', will provide an opportunity for the public to experience the brand's latest offerings.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:03 am

OKYO

OKYO Pharma has filed an Investigational New Drug (IND) application for OK-101, aimed at treating neuropathic corneal pain. The company plans to start enrolling for the study in Q1 2024, pending FDA approval.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:01 am

BBY

Best Buy has announced that it will start selling Continuous Glucose Monitoring Systems, marking the first time the company will offer prescription-based medical devices.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 10:02 am

EXAS

Exact Sciences Corp. (NASDAQ:EXAS) will present late-breaking data from the BLUE-C pivotal trial on next-generation Cologuard at the American College of Gastroenterology (ACG) Annual Meeting in October 2023. The company will also present further evidence supporting the cost-effectiveness and performance of next-generation Cologuard.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 10:00 am